Get key Q3 2025 insights on Vir Biotechnology’s accelerated hepatitis delta trial milestones, strong financials, and upcoming data catalysts.
Vir Biotechnology, Inc. ( ($VIR) ) has released its Q3 earnings. Here is a breakdown of the information Vir Biotechnology, Inc. presented to its ...
Vietnam Investment Review on MSN
Nona widens in vivo CAR T pact with Umoja
Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to I™), today announced an evaluation and license agreement with Umoja Biopharma ("Umoja"), the ...
A research team led by Professor Wang Peng from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences, ...
Shares of Lantheus Holdings declined after the radiopharmaceutical company’s second-quarter earnings results and guidance ...
The immune drugmaker is the second biotech, along with MapLight Therapeutics, to recently use a workaround in U.S. securities ...
Standard Glass Lining Technology Limited announced its results for the second quarter of FY26, marking another significant ...
Tech trends 2030 are reshaping business. Learn how AI, quantum computing, biotech, and emerging tools will drive the business ...
Motherly on MSN
A teacher used a vase to explain grief to her fourth graders—and parents everywhere are learning from it
When Ryan Brazil told her students, “We make space for each other,” she offered a truth that extends well beyond her ...
Obtained ex-US Regulatory Clearance for DT-818, a Potentially Best-in-Disease Treatment for Myotonic Dystrophy Type-1 (DM1) Trials of DT-216P2 in Friedreich Ataxia (FA) and DT-168 in Fuchs Endothelial ...
Unique in the world, Brazil’s Orion Project will integrate a maximum-level biological containment laboratory with the Sirius ...
A York biotech company has announced a major move that may see easier and quicker detection of lung cancer in the UK.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback